首页> 外文期刊>World Journal of Gastroenterology >Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India
【24h】

Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India

机译:印度北部慢性肝病患者原发性铁超负荷和HFE基因突变(C282Y,H63D和S65C)的发生频率

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To identify the frequency of iron overload and study the three mutations in the HFE gene (C282Y, H63D, and S65C) in patients with chronic liver disorders (CLD) and controls. METHODS: To identify patients with iron overload (transferrin saturation > 45% in females and > 50% in males and serum ferritin > 1000 ng/mL) we evaluated 236 patients with CLD, including 59 with non-alcoholic steatohepatitis (NASH), 22 with alcoholic liver disease (ALD), 19 of cirrhosis due to viruses (HBV, HCV), and 136 with cryptogenic cirrhosis. Mutations of the HFE gene were analyzed by PCR-RE. hundred controls were screened for iron status and the mutations. RESULTS: Seventeen patients with CLD showed evidence of iron overload. Fifteen cases of iron overload had cryptogenic cirrhosis and two had ALD. None of the controls showed iron overload. We did not find any individual with 282Y or 65C either in the cases or in the controls. The prevalence of H63D heterozygosity was 12% in normal individuals, 14.8% in 236 patients (16.9% in NASH, 13.6% in ALD, 26.3% in viral and 12.5% in cryptogenic cirrhosis) and the overall prevalence was 13.98%. Only two of the 17 patients with primary iron overload were heterozygous for H63D. One patient with NASH and one normal individual who were homozygous for H63D showed no iron overload. CONCLUSION: Primary iron overload in Indians is non-HFE type, which is different from that in Europeans and further molecular studies are required to determine the defect in various iron regulatory genes.
机译:目的:确定患有慢性肝病(CLD)和对照的患者的铁超载频率并研究HFE基因的三个突变(C282Y,H63D和S65C)。方法:为了确定铁超负荷的患者(女性转铁蛋白饱和度> 45%,男性> 50%,血清铁蛋白> 1000 ng / mL),我们评估了236名CLD患者,其中59例患有非酒精性脂肪性肝炎(NASH),22患有酒精性肝病(ALD),19例因病毒引起的肝硬化(HBV,HCV)和136例隐源性肝硬化。通过PCR-RE分析HFE基因的突变。筛选了一百个对照的铁状态和突变。结果:17名CLD患者表现出铁超负荷的证据。 15例铁超负荷患有隐源性肝硬化,2例患有ALD。没有控件显示铁过载。在病例或对照中,我们均未发现任何282Y或65C的个体。 H63D杂合性患病率在正常个体中为12%,在236例患者中为14.8%(NASH为16.9%,ALD为13.6%,病毒性肝硬化为26.3%,隐源性肝硬化为12.5%),总体患病率为13.98%。 17例原发性铁超负荷患者中只有2例为H63D杂合子。 1名NASH患者和1名H63D纯合子的正常人未显示铁超负荷。结论:印度人的原发性铁超载是非HFE类型,与欧洲人不同,因此需要进一步的分子研究来确定各种铁调节基因的缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号